PD-1 (PDCD1) Promoter Methylation Is a Prognostic Factor in Patients With Diffuse Lower-Grade Gliomas Harboring Isocitrate Dehydrogenase (IDH) Mutations.

EBioMedicine · 2018 · PMC5835568 · PMID 29396294

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Discussion In the present study, DNA promoter methylation of the immune checkpoint PD-1 was shown to serve as highly significant prognostic factor for overall survival in patients with LGG.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.